Pluri Inc. Financing Cash Flow
Pluri Inc. (PLUR) reported Financing Cash Flow of $7.04 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-09-10
- Pluri Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $2.82M.
- Pluri Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $1.38M.
- Pluri Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was -$435.00K.
- Pluri Inc. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was -$10.00K.
- Pluri Inc. net cash provided by (used in) financing activities for fiscal 2026 was $7.04M, a 26.17% decline from fiscal 2025.
- Pluri Inc. net cash provided by (used in) financing activities for fiscal 2025 was $9.53M, a 7.83% increase from fiscal 2024.
- Pluri Inc. net cash provided by (used in) financing activities for fiscal 2024 was $8.84M, a 10.18% increase from fiscal 2023.
- Pluri Inc. net cash provided by (used in) financing activities for fiscal 2023 was $8.02M, a 6.99% increase from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $4.20M derived: sum of 2 quarters · filed 2026-09-10 | $7.04M 10-K · filed 2026-09-10 | ||
| 2026-03-31 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | $4.22M 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $2.84M 10-Q · filed 2026-02-12 | ||||
| 2025-06-30 | -$435.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $9.53M 10-K · filed 2026-09-10 | |||
| 2025-03-31 | $9.97M 10-Q · filed 2026-05-14 | ||||
| 2024-06-30 | $8.84M 10-K · filed 2025-09-17 | ||||
| 2023-06-30 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $2.33M derived: sum of 2 quarters · filed 2024-09-18 | $8.02M 10-K · filed 2024-09-18 | ||
| 2023-03-31 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-09 | $8.03M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $5.69M 10-Q · filed 2024-02-12 | ||||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $7.50M 10-K · filed 2023-09-12 | |||
| 2022-03-31 | $7.50M 10-Q · filed 2023-05-09 | ||||
| 2021-06-30 | $24.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-21 | $60.12M derived: sum of 2 quarters · filed 2022-09-21 | $61.10M derived: sum of 3 quarters · filed 2022-09-21 | $61.40M 10-K · filed 2022-09-21 | |
| 2021-03-31 | $35.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09 | $36.69M derived: sum of 2 quarters · filed 2022-05-09 | $36.99M 10-Q · filed 2022-05-09 | $86.50M derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | $984.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07 | $1.28M 10-Q · filed 2022-02-07 | $50.79M derived: sum of 3 quarters · filed 2022-02-07 | $56.19M derived: sum of 4 quarters · filed 2022-02-07 | |
| 2020-09-30 | $300.00K 10-Q · filed 2021-11-08 | $49.81M derived: sum of 2 quarters · filed 2021-11-08 | $55.20M derived: sum of 3 quarters · filed 2021-11-08 | $59.19M derived: sum of 4 quarters · filed 2021-11-08 | |
| 2020-06-30 | $49.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-13 | $54.90M derived: sum of 2 quarters · filed 2021-09-13 | $58.89M derived: sum of 3 quarters · filed 2021-09-13 | $60.87M 10-K · filed 2021-09-13 | |
| 2020-03-31 | $5.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-06 | $9.38M derived: sum of 2 quarters · filed 2021-05-06 | $11.36M 10-Q · filed 2021-05-06 | $31.12M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | $3.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $5.97M 10-Q · filed 2021-02-08 | $25.72M derived: sum of 3 quarters · filed 2021-02-08 | $27.48M derived: sum of 4 quarters · filed 2021-02-08 | |
| 2019-09-30 | $1.98M 10-Q · filed 2020-11-05 | $21.74M derived: sum of 2 quarters · filed 2020-11-05 | $23.50M derived: sum of 3 quarters · filed 2020-11-05 | $24.98M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $19.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $21.52M derived: sum of 2 quarters · filed 2020-09-10 | $22.99M derived: sum of 3 quarters · filed 2020-09-10 | $23.58M 10-K · filed 2020-09-10 | |
| 2019-03-31 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $3.24M derived: sum of 2 quarters · filed 2020-05-11 | $3.83M 10-Q · filed 2020-05-11 | $6.43M derived: sum of 4 quarters · filed 2020-09-10 | |
| 2018-12-31 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $2.07M 10-Q · filed 2020-02-06 | $4.67M derived: sum of 3 quarters · filed 2020-09-10 | $6.06M derived: sum of 4 quarters · filed 2020-09-10 | |
| 2018-09-30 | $588.00K 10-Q · filed 2019-11-07 | $3.19M derived: sum of 2 quarters · filed 2020-09-10 | $4.58M derived: sum of 3 quarters · filed 2020-09-10 | $19.46M derived: sum of 4 quarters · filed 2020-09-10 | |
| 2018-06-30 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $4.00M derived: sum of 2 quarters · filed 2020-09-10 | $18.87M derived: sum of 3 quarters · filed 2020-09-10 | $19.92M 10-K · filed 2020-09-10 | |
| 2018-03-31 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-06 | $16.26M derived: sum of 2 quarters · filed 2019-05-06 | $17.31M 10-Q · filed 2019-05-06 | $17.38M derived: sum of 4 quarters · filed 2019-09-12 | |
| 2017-12-31 | $14.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | $15.93M 10-Q · filed 2019-02-06 | $15.99M derived: sum of 3 quarters · filed 2019-09-12 | $31.72M derived: sum of 4 quarters · filed 2019-09-12 | |
| 2017-09-30 | $1.05M 10-Q · filed 2018-11-07 | $1.12M derived: sum of 2 quarters · filed 2019-09-12 | $16.84M derived: sum of 3 quarters · filed 2019-09-12 | $16.84M derived: sum of 4 quarters · filed 2019-09-12 | |
| 2017-06-30 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | $15.79M derived: sum of 2 quarters · filed 2019-09-12 | $15.79M derived: sum of 3 quarters · filed 2019-09-12 | $15.80M 10-K · filed 2019-09-12 | |
| 2017-03-31 | $15.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $15.72M derived: sum of 2 quarters · filed 2018-05-09 | $15.73M 10-Q · filed 2018-05-09 | ||
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-06 | $4.00K 10-Q · filed 2018-02-06 | |||
| 2016-09-30 | $4.00K 10-Q · filed 2017-11-07 | ||||
| 2016-06-30 | $807.00K 10-K · filed 2018-09-12 | ||||
| 2015-06-30 | $17.20M 10-K · filed 2017-09-07 | ||||
| 2013-09-30 | $509.00K 10-Q · filed 2013-11-05 | $846.00K derived: sum of 2 quarters · filed 2013-11-05 | $36.78M derived: sum of 3 quarters · filed 2013-11-05 | $1.32M derived: sum of 4 quarters · filed 2013-11-05 | |
| 2013-06-30 | $337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $36.27M derived: sum of 2 quarters · filed 2013-09-11 | $810.00K derived: sum of 3 quarters · filed 2013-09-11 | $36.30M 10-K · filed 2013-09-11 | |
| 2013-03-31 | $35.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $473.00K derived: sum of 2 quarters · filed 2013-05-08 | $35.97M 10-Q · filed 2013-05-08 | $36.20M derived: sum of 4 quarters · filed 2013-11-05 | |
| 2012-12-31 | -$35.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-01-31 | $35.94K 10-Q · filed 2013-01-31 | $270.94K derived: sum of 3 quarters · filed 2013-11-05 | $667.54K derived: sum of 4 quarters · filed 2013-11-05 | |
| 2012-09-30 | $35.49M 10-Q · filed 2013-11-05 | $35.73M derived: sum of 2 quarters · filed 2013-11-05 | $36.13M derived: sum of 3 quarters · filed 2013-11-05 | $35.80M derived: sum of 4 quarters · filed 2013-11-05 | |
| 2012-06-30 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $631.60K derived: sum of 2 quarters · filed 2013-09-11 | $309.00K derived: sum of 3 quarters · filed 2013-09-11 | $632.00K 10-K · filed 2013-09-11 | |
| 2012-03-31 | $396.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $74.00K derived: sum of 2 quarters · filed 2013-05-08 | $397.00K 10-Q · filed 2013-05-08 | $810.00K derived: sum of 4 quarters · filed 2013-09-11 | |
| 2011-12-31 | -$322.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-01-31 | $400.00 10-Q · filed 2013-01-31 | $400.00K 10-Q · filed 2012-02-09 | $413.40K derived: sum of 3 quarters · filed 2013-09-11 | $42.03M derived: sum of 4 quarters · filed 2013-09-11 |
| 2011-09-30 | $323.00K 10-Q · filed 2012-11-06 | $736.00K derived: sum of 2 quarters · filed 2013-09-11 | $42.35M derived: sum of 3 quarters · filed 2013-09-11 | $47.13M derived: sum of 4 quarters · filed 2013-09-11 | |
| 2011-06-30 | $413.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $42.03M derived: sum of 2 quarters · filed 2013-09-11 | $46.81M derived: sum of 3 quarters · filed 2013-09-11 | $47.04M 10-K · filed 2013-09-11 | |
| 2011-03-31 | $41.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-08 | $46.40M derived: sum of 2 quarters · filed 2012-05-08 | $46.62M 10-Q · filed 2012-05-08 | ||
| 2010-12-31 | $4.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-09 | $5.01M 10-Q · filed 2012-02-09 | |||
| 2010-09-30 | $228.00K 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $5.95M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |